{"id":"https://openalex.org/W2069737223","doi":"https://doi.org/10.1111/cns.12137","title":"Effect of R osiglitazone, a PPAR \u2010\u03b3 Ligand on H aloperidol\u2010 I nduced C atalepsy","display_name":"Effect of R osiglitazone, a PPAR \u2010\u03b3 Ligand on H aloperidol\u2010 I nduced C atalepsy","publication_year":2013,"publication_date":"2013-06-21","ids":{"openalex":"https://openalex.org/W2069737223","doi":"https://doi.org/10.1111/cns.12137","mag":"2069737223","pmid":"https://pubmed.ncbi.nlm.nih.gov/23786164","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6493364"},"language":"en","primary_location":{"id":"doi:10.1111/cns.12137","doi":"https://doi.org/10.1111/cns.12137","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12137","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12137","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12137","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101519606","display_name":"Gaurav Gupta","orcid":"https://orcid.org/0000-0003-2844-3287","observed_orcids":["https://orcid.org/0000-0003-2844-3287"]},"institutions":[{"id":"https://openalex.org/I62370553","display_name":"IMU University","ror":"https://ror.org/04d4wjw61","country_code":"MY","type":"education","lineage":["https://openalex.org/I62370553"]}],"countries":["MY"],"is_corresponding":true,"raw_author_name":"Gaurav Gupta","raw_affiliation_strings":["Department of Life Sciences School of Pharmacy International Medical University Kuala Lumpur Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Life Sciences School of Pharmacy International Medical University Kuala Lumpur Malaysia","institution_ids":["https://openalex.org/I62370553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037824332","display_name":"Ramandeep Singh","orcid":"https://orcid.org/0000-0002-7101-6304","observed_orcids":["https://orcid.org/0000-0002-7101-6304"]},"institutions":[{"id":"https://openalex.org/I4210098857","display_name":"Government of Himachal Pradesh","ror":"https://ror.org/013bmyp84","country_code":"IN","type":"government","lineage":["https://openalex.org/I4210098857"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ramandeep Singh","raw_affiliation_strings":["Department of Pharmacology, Himachal Institute of Pharmacy, Paonta Sahib, Himachal Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Himachal Institute of Pharmacy, Paonta Sahib, Himachal Pradesh, India","institution_ids":["https://openalex.org/I4210098857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067865954","display_name":"Sheba Rani Nakka David","orcid":"https://orcid.org/0000-0001-7039-1041","observed_orcids":["https://orcid.org/0000-0001-7039-1041"]},"institutions":[{"id":"https://openalex.org/I62370553","display_name":"IMU University","ror":"https://ror.org/04d4wjw61","country_code":"MY","type":"education","lineage":["https://openalex.org/I62370553"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Sheba Rani David","raw_affiliation_strings":["Department of Life Sciences School of Pharmacy International Medical University Kuala Lumpur Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Life Sciences School of Pharmacy International Medical University Kuala Lumpur Malaysia","institution_ids":["https://openalex.org/I62370553"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024149680","display_name":"Rohit Kumar Verma","orcid":"https://orcid.org/0000-0003-4495-6779","observed_orcids":["https://orcid.org/0000-0003-4495-6779"]},"institutions":[{"id":"https://openalex.org/I62370553","display_name":"IMU University","ror":"https://ror.org/04d4wjw61","country_code":"MY","type":"education","lineage":["https://openalex.org/I62370553"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Rohit Kumar Verma","raw_affiliation_strings":["Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia","institution_ids":["https://openalex.org/I62370553"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101519606"],"corresponding_institution_ids":["https://openalex.org/I62370553"],"apc_list":{"value":4140,"currency":"USD","value_usd":4140},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"9","first_page":"724","last_page":"725"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.2215999960899353,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1088000014424324,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/ppargamma-ligands","display_name":"PPAR\u03b3 ligands","score":0.8619999885559082},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9679999947547913},{"id":"https://openalex.org/keywords/catatonia","display_name":"catatonia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5489117503166199},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4881483018398285},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48642969131469727},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.4731491804122925},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.4663170278072357},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.42972686886787415},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3958759009838104},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3623863756656647},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34314075112342834}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013482","descriptor_name":"Superoxide Dismutase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/cns.12137","doi":"https://doi.org/10.1111/cns.12137","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12137","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12137","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience & Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5559443","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6493364","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23786164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23786164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS neuroscience & therapeutics","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:6493364","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6493364/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neurosci Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/cns.12137","doi":"https://doi.org/10.1111/cns.12137","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12137","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12137","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2069737223.pdf","grobid_xml":"https://content.openalex.org/works/W2069737223.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2013164597","https://openalex.org/W2024639041","https://openalex.org/W2033756350","https://openalex.org/W2059045481","https://openalex.org/W2088866343","https://openalex.org/W2100480095"],"related_works":["https://openalex.org/W7008834605","https://openalex.org/W2059045481","https://openalex.org/W2290089913","https://openalex.org/W2383912243","https://openalex.org/W2024639041","https://openalex.org/W2373454021","https://openalex.org/W1973880316","https://openalex.org/W2751255375","https://openalex.org/W2083302419","https://openalex.org/W2033462482"],"abstract_inverted_index":{"Effect":[0],"of":[1],"Rosiglitazone":[2]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":10}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}